Microcirculatory Differences in Children With Congenital Heart Disease According to Cyanosis and Age

Rafael González1,2, Javier Urbano1,2,3, María J Solana1,2

  • 1Service of Paediatric Intensive Care, Gregorio Marañón General University Hospital, Madrid, Spain.

Insights

Congenital heart disease (CHD) patients with cyanotic defects exhibit higher microvascular density compared to non-cyanotic patients. Younger patients with CHD are more prone to reduced microvascular flow index, irrespective of defect type.

Area of Science:

  • Cardiovascular Medicine
  • Pediatric Cardiology
  • Medical Imaging

Background:

  • Congenital heart disease (CHD) is a leading cause of pediatric morbidity and mortality.
  • Microcirculatory alterations in CHD patients have been previously explored using various techniques.
  • Handheld videomicroscopy offers a non-invasive method for direct microcirculatory visualization.

Purpose of the Study:

  • To investigate microcirculatory differences in children with CHD.
  • To compare microcirculation based on the presence of cyanosis and patient age.

Main Methods:

  • Prospective observational study involving 30 CHD patients undergoing corrective surgery.
  • Sidestream dark field (SDF) imaging used for pre-operative microcirculation assessment.
  • Analysis of hemodynamic, respiratory, biochemical, and tissue perfusion parameters.

Main Results:

  • Cyanotic CHD patients demonstrated significantly higher total vessel density (TVD) and small vessel density compared to non-cyanotic patients.
  • Microvascular flow index (MFI) was lower in cyanotic patients, but this difference diminished after adjusting for age and PaO2.
  • Age showed a positive correlation with MFI, with younger patients exhibiting lower MFI values.

Conclusions:

  • SDF imaging reveals distinct microcirculatory patterns in CHD, with cyanotic defects associated with increased vascular density.
  • Microcirculatory dysfunction, indicated by low MFI, is more prevalent in younger CHD patients, independent of cyanotic status.

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
464
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.0K
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
303
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
288
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
523
Difference from Background: Limit of Detection01:05

Difference from Background: Limit of Detection

The limit of detection (LOD) is the smallest amount of analyte that can be distinguished from the background noise. The LOD value corresponds to the concentration at which the analyte signal is three times larger than the standard deviation of the blank signal. Below this value, the analyte signal cannot be differentiated from the background noise. It is calculated by dividing the calibration slope by 3 times the standard deviation of the blank signals.
The LOD indicates the presence or absence...
8.1K